30
Participants
Start Date
November 14, 2007
Primary Completion Date
March 5, 2020
Study Completion Date
March 5, 2020
Zevalin
(111In Zevalin) 5 millicurie (mCi) by vein and (90Y Zevalin) 0.4 mCI/kg by vein.
Carmustine
300 mg/m\^2 by vein.
Etoposide
200 mg/m\^2 by vein every 12 hours.
Cytarabine
200 mg/m\^2 by vein every 12 hours.
Melphalan
140 mg/m\^2 by vein.
Rituximab
"Arm 1, Arm 2 = 250 mg/m\^2 by vein;~Arm 1, Arm 2, Arm 3, Arm 4 = 1000 mg/m\^2 by vein following Stem Cell Transplant;~Arm 1, Arm 3 = 375 mg/m² by vein Maintenance Therapy."
Stem Cell Transplant
Injection of stem cells (Autologous SCT)
University of Texas MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER